Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
CH Pui, CG Mullighan, WE Evans… - Blood, The Journal of …, 2012 - ashpublications.org
Improved supportive care, more precise risk stratification, and personalized chemotherapy
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
[引用][C] Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
CH PUI, CG MULLIGHAN, WE EVANS, MV RELLING - Blood, 2012 - pascal-francis.inist.fr
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
CH Pui, CG Mullighan, WE Evans, MV Relling - Blood, 2012 - pubmed.ncbi.nlm.nih.gov
Improved supportive care, more precise risk stratification, and personalized chemotherapy
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
CH Pui, C Mullighan, W Evans, M Relling - 2012 - digital.library.adelaide.edu.au
Improved supportive care, more precise risk stratification, and personalized chemotherapy
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
CH Pui, CG Mullighan, WE Evans, MV Relling - Blood, 2012 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Improved supportive care, more precise risk
stratification, and personalized chemotherapy based on the characteristics of leukemic cells …
stratification, and personalized chemotherapy based on the characteristics of leukemic cells …
[HTML][HTML] Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
CH Pui, CG Mullighan, WE Evans, MV Relling - Blood, 2012 - Elsevier
Improved supportive care, more precise risk stratification, and personalized chemotherapy
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
[HTML][HTML] Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
CH Pui, CG Mullighan, WE Evans, MV Relling - Blood, 2012 - ncbi.nlm.nih.gov
Improved supportive care, more precise risk stratification, and personalized chemotherapy
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
CH Pui, CG Mullighan, WE Evans, MV Relling - Blood, 2012 - europepmc.org
Improved supportive care, more precise risk stratification, and personalized chemotherapy
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and …
[PDF][PDF] Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
CH Pui, CG Mullighan, WE Evans, MV Relling - BLOOD, 2012 - researchgate.net
Optimal use of existing antileukemic agents and improved supportive care in contemporary
clinical trials have improved the 5-year survival rate of childhood acute lymphoblastic …
clinical trials have improved the 5-year survival rate of childhood acute lymphoblastic …
[引用][C] Pediatric acute lymphoblastic leukemia: where are we going and how do we get there
CH Pui - Blood, 2012 - cir.nii.ac.jp